You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 3
  • Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence

 

Online download statistics by month:

Online download statistics by month: December 2019 to April 2025

AbstractFullPdf
Dec 2019020
Jan 2020021
Feb 2020031
May 2020020
Jun 2020050
Jul 2020020
Aug 2020010
Sep 2020050
Oct 2020010
Nov 2020020
Jan 2021011
Feb 2021032
Mar 2021020
Apr 2021040
May 2021011
Jul 2021010
Aug 2021010
Sep 2021012
Oct 2021030
Nov 2021024
Dec 2021070
Jan 2022041
Feb 2022010
Mar 2022010
Apr 2022051
May 2022061
Jun 2022031
Jul 2022020
Aug 2022020
Sep 2022020
Oct 2022050
Nov 2022060
Dec 2022060
Jan 2023010
Feb 2023020
Mar 2023010
May 2023010
Jun 2023011
Jul 2023012
Sep 2023040
Oct 2023051
Nov 2023031
Dec 20230140
Jan 2024020
Feb 20240112
Mar 2024057
Apr 202401010
May 2024086
Jun 2024041
Jul 2024081
Aug 2024072
Sep 2024042
Oct 2024057
Nov 2024031
Dec 2024023
Jan 2025086
Feb 2025023
Mar 2025025
Apr 2025016
Total020983